top of page

Rhea Brooking-Dixon, BS (Univ of Maryland Baltimore Co), PhD

Pathology Graduate Program (2002-2008)

Current Position: Senior Consultant

at Booz Allen Hamilton, Strategy and Technology Consulting Firm,

Washington DC

Publications from the Abraham Lab.

 Mast cell activators: a new class of highly effective vaccine adjuvants.McLachlan JB, Shelburne CP, Hart JP, Pizzo SV, Goyal R, Brooking-Dixon R, Staats HF, Abraham SN. Nat Med. 2008 May;14(5):536-41. Epub 2008 Apr 20.

 

Disruption of a nonribosomal peptide synthetase in Aspergillus fumigatus eliminates gliotoxin production.Cramer RA Jr, Gamcsik MP, Brooking RM, Najvar LK, Kirkpatrick WR, Patterson TF, Balibar CJ, Graybill JR, Perfect JR, Abraham SN, Steinbach WJ. Eukaryot Cell. 2006 (6):972-80.

bottom of page